Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients (Q36558327)
Jump to navigation
Jump to search
scientific article published on 17 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients |
scientific article published on 17 December 2012 |
Statements
1 reference
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients (English)
1 reference
Somnuek Sungkanuparph
1 reference
Weerawat Manosuthi
1 reference
Chonlaphat Sukasem
1 reference
Aroon Lueangniyomkul
1 reference
Wiroj Mankatitham
1 reference
Supeda Thongyen
1 reference
Samruay Nilkamhang
1 reference
Sukanya Manosuthi
1 reference
1 reference
Identifiers
1 reference